Author

Anna Rudel

Institution: Murdoch Children's Research Institute

Observed institution: Murdoch Children's Research Institute

OpenAlex ID: A5116310596

The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose

2025 · Nadia Mazarakis, Zheng Quan Toh, et al. · Journal of Infection · 16

Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia

2026 · Nadia Mazarakis, Zheng Quan Toh, et al. · Journal of Infection · 2

Immune responses and predictors of SARS-CoV-2 infection following a fourth dose of mRNA or protein-based COVID-19 vaccines

2026 · Paul Licciardi, Darren Ong, et al. · Research Square

Corrigendum to “The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose” [J Infect 90 (2025)/106447]

2026 · Nadia Mazarakis, Zheng Quan Toh, et al. · Journal of Infection

Corrigendum to ‘Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia’ [J Infect 92 (2026)/106727]

2026 · Nadia Mazarakis, Zheng Quan Toh, et al. · Journal of Infection

SARS-CoV-2 infection patterns and immune responses by fourth-dose COVID-19 vaccination status

2026 · Darren Ong, Nadia Mazarakis, et al. · Australian and New Zealand Journal of Public Health

Works count: 6

Citation count: 18

H-index: 2

I10-index: 1